In The News Posted February 23, 2021 Share Posted February 23, 2021 GUANGZHOU, China, Feb. 22, 2021 /PRNewswire/ -- AnchorDx Medical Co., Ltd. ("AnchorDx") announced the completion of a USD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.